UroGen Pharma (URGN) Misses Q4 EPS by 4c ; Offers Guidance
Go back to UroGen Pharma (URGN) Misses Q4 EPS by 4c ; Offers Guidance| (NASDAQ: URGN) | Delayed: 48.12 -0.88 (1.8%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $49.00 | 52 Week High | $ | |||
| Open | $49.60 | 52 Week Low | $ | |||
| Day High | $49.60 | P/E | N/A | |||
| Day Low | $47.67 | EPS | $ | |||
| Volume | 859,984 | |||||

